Australian team maps genetic variants linked to 16 diseases via immune cells

The significance here is methodological as much as biological: tying genetic variants to the behaviour of specific immune cell types gives drug developers a functional map rather than a list of statistical associations, which is what precision medicine has largely lacked. The work matters most to immunology and genomics researchers and to early-stage drug discovery teams hunting for validated targets across a wide set of diseases at once. Whether these cell-level links translate into druggable pathways, and whether the findings replicate beyond this cohort, are the open questions worth watching.